Musculoskeletal system disorders are the second-highest contributor to global disability and an estimated 20%–33% of people across the globe live with a painful musculoskeletal condition.
This report contains market size and forecasts of Musculoskeletal System Disorder in Global, including the following market information:
Global Musculoskeletal System Disorder Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Musculoskeletal System Disorder market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Rheumatoid Arthritis Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Musculoskeletal System Disorder include AB Science, AbGenomics International, Inc., Alder BioPharmaceuticals,Inc., Amgen Inc., Lexicon Pharmaceuticals, Inc., LG Chem, OrthoTrophix, Inc., Tarsa Therapeutics, Inc. and PhytoHealth Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Musculoskeletal System Disorder companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Musculoskeletal System Disorder Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Musculoskeletal System Disorder Market Segment Percentages, by Type, 2021 (%)
Rheumatoid Arthritis
Osteoarthritis
Osteoporosis
Others
Global Musculoskeletal System Disorder Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Musculoskeletal System Disorder Market Segment Percentages, by Application, 2021 (%)
Hospitals & Clinics
Academic & Research Institutes
Global Musculoskeletal System Disorder Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Musculoskeletal System Disorder Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Musculoskeletal System Disorder revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Musculoskeletal System Disorder revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AB Science
AbGenomics International, Inc.
Alder BioPharmaceuticals,Inc.
Amgen Inc.
Lexicon Pharmaceuticals, Inc.
LG Chem
OrthoTrophix, Inc.
Tarsa Therapeutics, Inc.
PhytoHealth Corporation
Eisai Co., Ltd
Astellas Pharma Inc.
AstraZeneca
Baxter
GlaxoSmithKline PLC